Legend Biotech Management
Management criteria checks 2/4
Legend Biotech's CEO is Ying Huang, appointed in Sep 2020, has a tenure of 4.08 years. directly owns 0.035% of the company’s shares, worth $3.21M. The average tenure of the management team and the board of directors is 2.4 years and 3.3 years respectively.
Key information
Ying Huang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.03% |
| Management average tenure | 2.4yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion
Sep 18Optimistic Investors Push Legend Biotech Corporation (NASDAQ:LEGN) Shares Up 26% But Growth Is Lacking
Aug 01
Legend Biotech's Promising CAR-T Therapies Face Valuation And Cash Burn Challenges
Jul 30Rock star Growth Puts Legend Biotech (NASDAQ:LEGN) In A Position To Use Debt
Jul 05Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances
May 14Some Shareholders Feeling Restless Over Legend Biotech Corporation's (NASDAQ:LEGN) P/S Ratio
May 13Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)
Mar 15Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?
Mar 06Legend Biotech: Solid Traction With Carvykti Rollout
Jan 29Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up
Jan 16Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?
Nov 09Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?
Apr 12An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 44% Undervalued
Dec 14Legend Biotech wins approval of Carvykti for multiple myeloma in Japan
Sep 27Legend Biotech stock slides on proposed ADS offering
Jul 25Legend Biotech ends Phase 1 trial for lymphoma candidate
Jul 07News Flash: Analysts Just Made A Notable Upgrade To Their Legend Biotech Corporation (NASDAQ:LEGN) Forecasts
Jun 05Legend Biotech (NASDAQ:LEGN) Has Debt But No Earnings; Should You Worry?
May 14Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Full-Year Results
Mar 22Legend Biotech: Carvykti Approval Makes For A Buy Opportunity
Mar 04Legend Biotech Corporation (NASDAQ:LEGN) Analysts Are More Bearish Than They Used To Be
Mar 03Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?
Dec 30CEO
Ying Huang (51 yo)
4.1yrs
Tenure
Dr. Ying Huang, Ph D., had been Chief Financial Officer of Legend Biotech Corporation since July 2019 until May 09, 2022 and was its Interim Chief Executive Officer since September 21, 2020 until November...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.1yrs | no data | 0.035% $ 3.2m | |
| Chief Financial Officer | 2.4yrs | no data | 0.0031% $ 281.0k | |
| Vice President of Global Operations | less than a year | no data | no data | |
| Chief Scientific Officer & Head of Business Development | no data | no data | no data | |
| Senior Manager of Investor Relations | no data | no data | no data | |
| General Counsel | less than a year | no data | no data | |
| Global Compliance Officer | less than a year | no data | no data | |
| Executive Director of Strategic Marketing & Corporate Communications | no data | no data | no data | |
| VP & Global Head of Human Resources | 1.5yrs | no data | no data | |
| Senior Vice President of Global Regulatory Affairs | 2.8yrs | no data | no data | |
| Senior Vice President of Commercial Development | 2.8yrs | no data | no data | |
| Senior Vice President of Global Quality | 2.8yrs | no data | no data |
2.4yrs
Average Tenure
Experienced Management: LEGN's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.8yrs | no data | 0.035% $ 3.2m | |
| Member of Strategic Advisory Board | 1.5yrs | no data | no data | |
| Non-Independent Director | 3.9yrs | no data | no data | |
| Independent Director | 4.4yrs | no data | 0.010% $ 960.1k | |
| Independent Director | 4.4yrs | no data | 0.0050% $ 460.7k | |
| Independent Director | 2.2yrs | no data | 0.0011% $ 101.4k | |
| Independent Chairman | 2.2yrs | no data | 0% $ 0 | |
| Director | 9.4yrs | no data | 0% $ 0 | |
| Member of Strategic Advisory Board | 1.5yrs | no data | no data | |
| Independent Director | 4.4yrs | no data | 0.0010% $ 94.0k | |
| Independent Director | 3.8yrs | no data | 0.0069% $ 633.0k | |
| Independent Director | 2.2yrs | no data | 0.0019% $ 173.2k |
3.3yrs
Average Tenure
62yo
Average Age
Experienced Board: LEGN's board of directors are considered experienced (3.3 years average tenure).